» Labs » Peters

Apr 23, 2021 Immune Matters

Q&A with Bjoern Peters, Ph.D.

The bioinformatics tools Dr. Peters has developed are invaluable for immunologists worldwide.

Feb 16, 2021 Cell Rep Med.

Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases

Tarke A, Sidney J, Kidd CK, Dan JM, Ramirez SI, Yu ED, Mateus J, da Silva Antunes R, Moore E, Rubiro P, Methot N, Phillips E, Mallal S, Frazier A, Rawlings SA, Greenbaum JA, Peters B, Smith DM, Crotty S, Weiskopf D, Grifoni A, Sette A.

Jan 6, 2021 Science

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, Faliti CE, Grifoni A, Ramirez SI, Haupt S, Frazier A, Nakao C, Rayaprolu V, Rawlings SA, Peters B, Krammer F, Simon V, Saphire EO, Smith DM, Weiskopf D, Sette A, Crotty S.

Nov 19, 2020 Institute News

Inside the labs of three leading San Diego scientists

LA JOLLA—Studying the immune system means venturing into uncharted territory, leading explorations of the countless immune cells and genetic players

Aug 27, 2020 Front Neurosci

T cell responses to neural autoantigens are similar in Alzheimer’s disease patients and age-matched healthy controls

Dhanwani R, Sulzer D, Sette A, Lindestam Arlehamn CS

Oct 2, 2020 Cell

Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction

Wells DK, van Buuren MM, Dang KK, Hubbard-Lucey VM, Sheehan KCF, Campbell KM, Lamb A, Ward JP, Sidney J, Blazquez AB, Rech AJ, Zaretsky JM, Comin-Anduix B, Ng AHC, Chour W, Yu TV, Rizvi H, Chen JM, Manning P, Steiner GM, Doan XC; Tumor Neoantigen Selection Alliance, Merghoub T, Guinney J, Kolom A, Selinsky C, Ribas A, Hellmann MD, Hacohen N, Sette A, Heath JR, Bhardwaj N, Ramsdell F, Schreiber RD, Schumacher TN, Kvistborg P, Defanoux NA

Sep 29, 2020 Proc Natl Acad Sci

Lack of evidence for BCG vaccine protection from severe COVID-19

Lindestam Arlehamn CS, Sette A, Peters B

Sep 28, 2020 Cytokine

Lack of evidence supporting a role of IFN-b and TGF-b iin differential polarization of Bordetella pertussis specific-T cell responses

da Silva Antunes R, Quiambao LG, Soldevila F, Sutherland A, Peters B, Sette A

Sep 29, 2020 Circulation

Pathogenic Autoimmunity in Atherosclerosis Evolves From Initially Protective Apolipoprotein B100-Reactive CD4(+) T-Regulatory Cells

Wolf D, Gerhardt T, Winkels H, Michel NA, Pramod AB, Ghosheh Y, Brunel S, Buscher K, Miller J, McArdle S, Baas L, Kobiyama K, Vassallo M, Ehinger E, Dileepan T, Ali A, Schell M, Mikulski Z, Sidler D, Kimura T, Sheng X, Horstmann H, Hansen S, Mitre LS, Stachon P, Hilgendorf I, Gaddis DE, Hedrick C, Benedict CA, Peters B, Zirlik A, Sette A, Ley K

Aug 4, 2020 Immunohorizons

Proteome-wide Zika virus CD4 T cell epitope and HLA restriction determination. Immunohorizons

Campbell VL, Nguyen L, Snoey E, McClurkan CL, Laing KJ, Dong L, Sette A, Lindestam Arlehamn CS, Altmann DM, Boyton RJ, Roby JA, Gale Jr M, Stone M, Busch MP, Norris PJ, Koelle DM

Sep 16, 2020 Cell

Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity

Rydyznski Moderbacher C, Ramirez SI, Dan JM, Grifoni A, Hastie KM, Weiskopf D, Belanger S, Abbott RK, Kim C, Choi J, Kato Y, Crotty EG, Kim C, Rawlings SA, Mateus J, Tse LPV, Frazier A, Baric R, Peters B, Greenbaum J, Ollmann Saphire E, Smith DM, Sette A, Crotty S

Feb 25, 2020 SSRN

Candidate targets for immune responses to 2019-novel coronavirus (nCoV): sequence homology- and bioinformatic-based predictions

Grifoni A, Sidney J, Zhang Y, Scheuermann RH, Peters B, Sette A